What Do Semaglutide Results Look Like After 1 Week?

The starting dose of semaglutide (0.25 mg weekly) is a tolerability dose — its job is to let your system settle in, not to produce immediate weight loss.
Appetite changes are the earliest signal most people notice, often within 2–5 days of the first injection.
GI side effects such as nausea, constipation or mild stomach discomfort are common in week one and usually ease within a fortnight.
Visible weight changes in week one are modest at most, meaningful loss builds over weeks and months of treatment, as clinical trial data consistently shows.

After a first semaglutide injection, most people notice changes within days — though rarely the ones they expect. The first week is about your body adjusting to the medicine, not about seeing a number drop on the scales. Some people feel less hungry almost immediately; others notice mild nausea before anything else. Both are normal. Semaglutide is a prescription-only medicine, and what you experience in week one depends on your starting dose, your individual response, and how well you support the medicine with food and hydration choices. A prescriber assesses your suitability before treatment begins and guides any changes along the way.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The honest week-one picture: appetite, side effects, and what the evidence actually says

Does semaglutide actually do anything in the first seven days?

Yes, just not always what people are watching for. Semaglutide works by activating GLP-1 receptors in the brain and gut, slowing gastric emptying and signalling fullness. Those mechanisms can kick in quickly. Many people report eating noticeably less at their first or second meal after the injection, finishing portions they would previously have cleared without thinking. That early appetite shift is real, and it matters, it is what drives weight loss over time.

What you are unlikely to see after seven days is a dramatic fall on the scales. The opening dose (0.25 mg) is set intentionally low. Its purpose is to reduce the risk of nausea and vomiting as your body adapts, not to produce the weight-loss effect that comes at higher maintenance doses. The longer arc of semaglutide results shows that the medicine's effects compound through the titration schedule, which typically runs over several months.

A practical check you can do right now: jot down roughly how hungry you felt before your injection, then check in again 48–72 hours after. Many people find the contrast is sharper than they expected, even if the scales have not moved yet.

Why do some people feel worse before they feel better?

Nausea is the most commonly reported side effect in week one, and it catches people off guard because they were expecting to feel better, not worse. It happens because slowing gastric emptying (the same mechanism that reduces appetite) also means food sits in the stomach longer than your body is used to. For most people, the nausea is mild to moderate and settles within one to two weeks as the body adjusts.

Other GI effects in the early days can include constipation, loose stools, burping, or a general feeling of stomach fullness. Headache and mild fatigue are also reported. None of these are signs the medicine is not working, they are signs it is working, and that your system is responding. The timeline for Wegovy to work covers this adjustment period in more detail, including what to expect as doses increase.

Eating smaller portions, choosing lower-fat foods, and staying well hydrated can meaningfully reduce nausea in the first weeks. If symptoms are severe or persistent, contact your prescriber, do not simply stop the medicine.

How does week one compare to what the clinical trials found overall?

The STEP 1 trial, published in the New England Journal of Medicine, followed adults using semaglutide 2.4 mg alongside lifestyle changes over 68 weeks. The average weight reduction reached around 15% of body weight. That figure reflects 68 weeks of treatment at the full maintenance dose, not week one at 0.25 mg.

Week one sits right at the start of a long curve. The titration from 0.25 mg through 0.5 mg, 1.0 mg, 1.7 mg and up to 2.4 mg happens gradually, typically over several months, guided by a prescriber. The appetite suppression and weight-loss effects strengthen as the dose increases. People often notice the clearest difference in weeks four to eight, you can read about what changes around that point on our semaglutide four-week results page.

The NHS semaglutide medicines page also sets out what to expect, including side effects and storage guidance, and is worth reading alongside your Patient Information Leaflet.

Is week-one experience a useful predictor of how well the medicine will work for you?

Partly, but not in the way most people assume. Feeling nauseous in week one does not mean the medicine will work better for you. Feeling no side effects does not mean it will not work. Both are poor predictors of long-term outcome. What matters more is consistency, taking each weekly dose at a roughly similar point in the week, following your prescriber's titration schedule, and pairing treatment with the kind of sustainable lifestyle changes that the clinical evidence shows make a real difference alongside GLP-1 medicines.

Some people do see small scale changes in week one (often related to reduced food intake and some fluid shifts) but these vary widely and should not be used to judge whether treatment is working. The week-by-week semaglutide results guide maps out what each phase of treatment typically brings, which is a more useful lens than a single early reading.

Semaglutide (Wegovy) is a prescription-only medicine. If you are considering treatment, or want to understand whether it could be right for you, our Wegovy overview covers eligibility, the titration process, and how private treatment works. For those thinking about the cost side, our Wegovy cost page explains what a legitimate private prescription includes. When you are ready to speak to a prescriber, start a free consultation with our team, a real clinician reviews your information the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions